Industries/ Healthcare & Life Sciences/ Biotech Research

Biotech Research on PYRAX

Biotech R&D is capital-intensive, IP-sensitive, and increasingly collaborative across institutions that cannot freely share data. PYRAX protects research IP with tamper-evident provenance, funds and coordinates consortia through escrow and multi-VM contracts, and enables cross-lab AI via PYRAX Compute compute-to-data — so collaboration never means surrendering a lab's crown-jewel datasets.

Market size

$1.55T biotechnology market (2023)

Projection

$3.88T by 2030 · ~13.9% CAGR

The market

~13.9%

Biotech market CAGR to 2030

hundreds of $B/yr

Global biotech R&D spend

~50%

Research findings that fail to replicate

common

IP disputes and prior-art contests

Source: Grand View Research, 2024. Figures are indicative and provided for context.

What's broken today

Proving invention priority and data provenance for IP is slow and contestable.

Cross-institution collaboration is throttled by inability to share proprietary datasets.

Reproducibility suffers because raw data and methods are opaque and unverifiable.

Consortium funding and milestone payments are administratively heavy and low-trust.

How PYRAX transforms it

Concrete network elements mapped to this business.

eth_getProof IP and data provenance

Experimental results and lab-notebook entries are timestamped commitments, giving cryptographic proof of invention priority and data integrity for patents and disputes.

PYRAX Compute compute-to-data collaboration

Partner labs jointly train models across each other's private datasets in place, so a consortium gets combined power without any lab exposing its proprietary data.

On-chain escrow for consortium funding

Grant and consortium funds release from escrow against verified research milestones, cutting administrative overhead and building funder trust.

Shielded-by-default IP

Proprietary methods and results stay off-chain as commitments — provenance and integrity are provable while trade secrets remain confidential.

Multi-VM contracts for licensing and royalties

EVM/WASM/Cairo contracts automate data-use agreements, IP licensing, and royalty splits between collaborating institutions.

Buildathon: dApp ideas

Ship-ready concepts for biotech research on PYRAX.

Start building →

LabNotarize

Tamper-evident electronic lab notebook committing every result for provable invention priority.

eth_getProofprovenanceIP

ConsortiumAI

PYRAX Compute cross-lab model training that pools statistical power without moving any proprietary dataset.

Computecompute-to-dataAI

GrantEscrow

Milestone-gated funding contract releasing consortium capital on verified research deliverables.

escrowfundingEVM

ReproProof

Reproducibility registry publishing method and data commitments so results can be independently verified.

integritycommitmenttransparency

LicenseFlow

IP-licensing and royalty-split contract automating cross-institution data-use agreements.

EVMroyaltieslicensing

AssayVault

Shielded assay-data exchange where labs trade result commitments without exposing raw screens.

ZKcommitmentcollaboration

PriorArtChain

Timestamped disclosure registry establishing defensible prior art for patent strategy.

provenanceIPaudit

BioMarketAI

PYRAX Compute target-discovery marketplace where sponsors run inference against private compound and omics libraries.

Computemarketplaceinference

← Genomics All Healthcare & Life Sciences Mental Health →